How genes linked to neurodevelopmental and psychiatric conditions change the developing brain

Cross Scale Interrogation of NPD Genes (SING) in mice

NIH-funded research Pennsylvania State Univ Hershey Med Ctr · NIH-11258977

This work looks at how removing genes tied to neurodevelopmental and psychiatric conditions changes brain cells, wiring, and behavior in mice to help people with those conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr NIH-funded
Lab location1 site (Hershey, United States)
Project IDNIH-11258977 on NIH RePORTER

What this research studies

Researchers will delete 100 genes linked to neurodevelopmental and psychiatric disorders in mice and follow changes across development. They will measure gene activity in single cells and map where genes are active in brain tissue, scan brain anatomy and circuits with MRI and high-resolution 3D mapping, and record mouse behaviors. The team combines high-throughput methods and integrated data analysis to connect molecular and cellular changes to circuit and behavioral outcomes. Results aim to reveal shared pathways that could guide future diagnostics and treatments.

Who could benefit from this research

Good fit: People most relevant are individuals and families affected by neurodevelopmental disorders such as autism, intellectual disability, epilepsy, or those with genetic variants linked to psychiatric conditions.

Not a fit: Patients with conditions unrelated to neurodevelopmental or psychiatric gene changes, or whose symptoms are driven solely by non-genetic environmental factors, may not see direct benefit from these mouse-focused experiments.

Why it matters

Potential benefit: If successful, the project could reveal shared biological pathways behind many neurodevelopmental and psychiatric conditions, pointing to targets for future diagnostics and therapies.

How similar studies have performed: Previous single-gene knockout and mouse-model studies have clarified mechanisms for some risk genes, but combining single-cell, spatial, MRI/3D mapping, and behavioral analysis across 100 genes at this scale is largely novel.

Where this research is happening

Hershey, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.